Drug Controller General of India Calls Industry Meeting On Fixed-Dose Combinations Ban
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - The head of India's Central Drug Control Administration has asked industry associations to discuss a ban on almost 300 fixed-dose drug combinations on June 10, according to a spokesman for the agency, which regulates the manufacture, sale and distribution of drugs